Abstract:The screening and testing of extracts against a variety of pharmacological targets in order to benefit from the immense natural chemical diversity is a concern in many laboratories worldwide. And several successes have been recorded in finding new actives in natural products, some of which have become new drugs or new sources of inspiration for drugs. But in view of the vast amount of research on the subject, it is surprising that not more drug candidates were found. In our view, it is fundamental to reflect upon the approaches of such drug discovery programs and the technical processes that are used, along with their inherent difficulties and biases. Based on an extensive survey of recent publications, we discuss the origin and the variety of natural chemical diversity as well as the strategies to having the potential to embrace this diversity. It seemed to us that some of the difficulties of the area could be related with the technical approaches that are used, so the present review begins with synthetizing some of the more used discovery strategies, exemplifying some key points, in order to address some of their limitations. It appears that one of the challenges of natural product-based drug discovery programs should be an easier access to renewable sources of plant-derived products. Maximizing the use of the data together with the exploration of chemical diversity while working on reasonable supply of natural product-based entities could be a way to answer this challenge. We suggested alternative ways to access and explore part of this chemical diversity with <i>in vitro</i> cultures. We also reinforced how important it was organizing and making available this worldwide knowledge in an "inventory" of natural products and their sources. And finally, we focused on strategies based on synthetic biology and syntheses that allow reaching industrial scale supply. Approaches based on the opportunities lying in untapped natural plant chemical diversity are also considered.

Drugs from drugs: New chemical insights into a mature concept

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Repurposing of Drugs: Updates and New Perspectives

Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editing

NATURAL PRODUCTS: FROM TRADITIONAL MEDICINE TO LEAD COMPOUNDS FOR DRUG DEVELOPMENT IN THE 21ST CENTURY

Repurposing – second life for drugs

Current approaches in identification of a novel drug targets for drug repurposing

Capturing Biological Activity in Natural Product Fragments by Chemical Synthesis

Drug Repurposing: Far Beyond New Targets for Old Drugs

Drug Design—Past, Present, Future

Prodrug Rewards in Medicinal Chemistry: An Advance and Challenges Approach for Drug Designing

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes

Transition-Metal-Catalyzed Transformations for the Synthesis of Marine Drugs

Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products

Overview of Recent Strategic Advances in Medicinal Chemistry

The landscape of small-molecule prodrugs

Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases

Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines

Techniques and Strategies in Drug Design and Discovery